| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.4M | +18.5% |
| R&D Expense | $1.5M | -0.5% |
| SG&A Expense | $9.9M | +46.4% |
| Operating Income | -$9.0M | -12.3% |
| Pre-tax Income | -$9.0M | -14.0% |
| Income Tax | $12K | -44.5% |
| Net Income | -$9.0M | -13.9% |
| EPS (Basic) | -$0.75 | +17.6% |
| EPS (Diluted) | -$0.75 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.1M | -60.8% |
| Accounts Receivable | $1.1M | +40.4% |
| Inventory | $28K | +49.4% |
| Current Assets | $2.7M | -32.2% |
| Total Assets | $6.5M | -20.8% |
| Current Liabilities | $3.1M | +38.1% |
| Total Liabilities | $3.9M | +16.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.3M | -20.3% |
| Capital Expenditures | $79K | +245.3% |
| Investing Cash Flow | -$79K | +96.4% |
| Financing Cash Flow | $5.6M | +1731.3% |
| Free Cash Flow | -$7.3M | -21.2% |
| +17.6% |
| Stockholders' Equity |
| $2.6M |
| -46.4% |